Published in
Elsevier, Annals of Oncology, (33), p. S817, 2022
DOI: 10.1016/j.annonc.2022.07.720
Links
Tools
592P Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer
Journal article published in 2022 by
U. A. Matulonis,
K. N. Moore,
D. Lorusso,
A. Oaknin,
S. Pignata,
H. Denys,
N. Colombo,
T. Van Gorp 
,
J. Konner,
M. Romeo Marin,
P. Harter,
C. Murphy,
Y. Tu,
F. Zhu,
B. Esteves
and other authors.
,
J. Konner,
M. Romeo Marin,
P. Harter,
C. Murphy,
Y. Tu,
F. Zhu,
B. Esteves
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 